SGLT2 Inhibitors Treatment Market - Top Companies and Manufacturers

  • Report ID: 3972
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Companies Dominating the SGLT2 Inhibitors Treatment Landscape

top-features-companies
    • Novartis International AG
    • Company overview
    • Business strategy
    • Key product offerings
    • Financial performances
    • Key performance indicators
    • Risk analysis
    • Recent development
    • Regional presence
    • SWOT analysis
    • Boehringer Ingelheim GmbH
    • Janssen pharmaceuticals
    • GRUPO TECNIMEDE
    • Unichem Laboratories Ltd.
    • Edificio Bluepharma

Browse Key Market Insights with Data Illustration:

In the News

  • Astellas Pharma Inc., announced that selective SGLT2 inhibitor Suglat Tablets 25mg and 50mg Ipragliflozin L-Proline, “Suglat Tablets”) became available for the indication of type 2 diabetes in the Japanese market today.
  • AstraZeneca’s Forxiga (dapagliflozin) was approved in China to reduce the risk of cardiovascular (CV) death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF).

Author Credits:  Radhika Pawar


  • Report ID: 3972
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of SGLT2 inhibitors treatment is estimated at USD 6.36 Billion.

The SGLT2 inhibitors treatment market size was over USD 5.86 Billion in 2023 and is likely to cross USD 19.06 Billion by the end of 2036, growing at more than 9.5% CAGR during the forecast period i.e., between 2024-2036. Growing Concern for the Prevalence of diabetes mellitus is estimated to boost the SGLT2 inhibitor treatment market.

North America industry is estimated to have the highest revenue share of 32% by 2036, impelled by increasing prevalence of obesity and lifestyle changes in the region.

Novartis International AG, Financial performancesBoehringer Ingelheim GmbH, Janssen pharmaceuticals, GRUPO TECNIMEDE, Unichem Laboratories Ltd., Edificio Bluepharma
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying